Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allory, Y.
Right arrow Articles by Debiec, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allory, Y.
Right arrow Articles by Debiec, H.
Clinical Cancer Research Vol. 11, 1190-1197, February 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

The L1 Cell Adhesion Molecule Is Induced in Renal Cancer Cells and Correlates with Metastasis in Clear Cell Carcinomas

Yves Allory1, Yasuko Matsuoka1, Céline Bazille2, Erik Ilsø Christensen3, Pierre Ronco1 and Hanna Debiec1

1 Institut National de la Santé et de la Recherche Médicale U489 and 2 Department of Pathology, Tenon Hospital (Assistance Publique-Hôpitaux de Paris) and Paris 6 University, Paris, France and 3 Department of Cell Biology Institute of Anatomy, University of Aarhus, Denmark

Requests for reprints: Hanna Debiec, Institut National de la Sante et de la Recherche Medicale U489, Hôpital Tenon, 4 rue de la Chine, Paris 75020, France. Phone: 33-1-56-01-65-14; Fax: 33-1-56-01-62-17. E-mail: hanna.debiec{at}tnn.ap-hop-paris.fr.

Purpose: The L1 cell adhesion molecule is overexpressed in many human carcinomas. The objectives of the study were to provide a comprehensive description of L1 distribution in human kidney and to establish the prognostic relevance of L1 expression in renal cell carcinomas (RCC).

Experimental Design: Using two antibodies to the extracellular part and the cytoplasmic domain, respectively, we first compared L1 expression in normal kidney and renal tumors of diverse histopathologic origin, then we studied L1 expression together with tumor stage, grade, molecular prognostic biomarkers, and metastatic behavior.

Results: In normal kidney, L1 immunoreactive with both antibodies was expressed in all epithelial cells originating from the ureteric bud except for intercalated cells. In renal tumors, L1 was mainly detected in those originating from cells that do not express L1 in the normal kidney [i.e., 33 of 72 clear cell RCC (ccRCC) and 25 of 88 papillary RCC (papRCC)]. Both in ccRCC and papRCC, L1 reacted only with the antibody to the extracellular domain, suggesting that the protein was truncated. In these carcinomas, L1 expression was strongly correlated with Ki-67 proliferation index (ccRCC, P = 0.0059; papRCC, P = 0.0039), but only in ccRCC, the presence of L1 was associated with the risk of metastasis (P = 0.0121). This risk was higher if cyclin D1 was concurrently absent in tumor cells (P < 0.0001). The L1+/cyclin D1 profile was an independent prognostic factor of metastasis occurrence in multivariate analysis (P = 0.0023).

Conclusion: We have found a combination of markers that can serve to identify a subgroup of high-risk patients with ccRCC that may require more aggressive therapies.

Key Words: prognostic markers • metastasis • tissue microarray • immunohistochemistry




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Bao, Q. Wu, Z. Li, S. Sathornsumetee, H. Wang, R. E. McLendon, A. B. Hjelmeland, and J. N. Rich
Targeting Cancer Stem Cells through L1CAM Suppresses Glioma Growth
Cancer Res., August 1, 2008; 68(15): 6043 - 6048.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Wachowiak, H. C. Fiegel, J. T. Kaifi, A. Quaas, A. Krickhahn, P. G. Schurr, R. Erttmann, M. Schachner, D. Kluth, G. Sauter, et al.
L1 Is Associated With Favorable Outcome in Neuroblastomas in Contrast to Adult Tumors.
Ann. Surg. Oncol., December 1, 2007; 14(12): 3575 - 3580.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
Y.-J. Boo, J.-M. Park, J. Kim, Y.-S. Chae, B.-W. Min, J.-W. Um, and H.-Y. Moon
L1 Expression as a Marker for Poor Prognosis, Tumor Progression, and Short Survival in Patients with Colorectal Cancer
Ann. Surg. Oncol., May 1, 2007; 14(5): 1703 - 1711.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Shtutman, E. Levina, P. Ohouo, M. Baig, and I. B. Roninson
Cell Adhesion Molecule L1 Disrupts E-Cadherin-Containing Adherens Junctions and Increases Scattering and Motility of MCF7 Breast Carcinoma Cells
Cancer Res., December 1, 2006; 66(23): 11370 - 11380.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. E. Barbieri, L. J. Tang, K. A. Brown, and J. A. Pietenpol
Loss of p63 Leads to Increased Cell Migration and Up-regulation of Genes Involved in Invasion and Metastasis.
Cancer Res., August 1, 2006; 66(15): 7589 - 7597.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y. Allory, F. Commo, L. Boccon-Gibod, M. Sibony, P. Callard, P. Ronco, and H. Debiec
Sulfated HNK-1 Epitope in Developing and Mature Kidney: A New Marker for Thin Ascending Loop of Henle and Tubular Injury in Acute Tubular Necrosis
J. Histochem. Cytochem., May 1, 2006; 54(5): 575 - 584.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J.E. Arlt, I. Novak-Hofer, D. Gast, V. Gschwend, G. Moldenhauer, J. Grunberg, M. Honer, P. A. Schubiger, P. Altevogt, and A. Kruger
Efficient Inhibition of Intra-Peritoneal Tumor Growth and Dissemination of Human Ovarian Carcinoma Cells in Nude Mice by Anti-L1-Cell Adhesion Molecule Monoclonal Antibody Treatment
Cancer Res., January 15, 2006; 66(2): 936 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Plaisier, B. Mougenot, M. C. Verpont, C. Jouanneau, J. J. Archelos, R. Martini, D. Kerjaschki, and P. Ronco
Glomerular Permeability Is Altered by Loss of P0, a Myelin Protein Expressed in Glomerular Epithelial Cells
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3350 - 3356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.